Halozyme Therapeutics, Inc. (HALO): Weighted Average Diluted Shares
123.90M
Year ended 2025-12-31
-4.1%
3-year compound annual growth
-2.6%
5-year compound annual growth
-0.2%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 123.90M | -4.3% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | 129.42M | -3.6% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | 134.20M | -4.6% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | 140.61M | -4.2% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | 146.80M | +3.8% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | 141.46M | -2.0% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | 144.33M | +0.5% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | 143.60M | +3.3% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | 139.07M | +8.7% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | 127.96M | +1.0% | 2019-02-21, From 2016-01-01 |
| 2015-12-31 | 126.70M | n/a | 2018-02-20, From 2015-01-01 |